Age-Like Methylation Changes of HSCs in GADD45B Knockout Mice Define Methylation Sites Associated With Loss of

Wakako Kuribayashi1, Mayuri Tanaka-Yano1, Bongsoo Park1

  • 1Epigenetics and Stem Cell Aging Unit, TGB, National Institute on Aging, NIH, Baltimore, Maryland, USA.

Aging Cell
|March 20, 2026
PubMed

Insights

Growth Arrest and DNA Damage-inducible protein beta (Gadd45b) influences DNA methylation in hematopoietic stem cells (HSCs). Gadd45b knockout HSCs show altered methylation but retain functional potential, suggesting these sites do not drive age-related HSC dysfunction.

Area of Science:

  • Hematology
  • Epigenetics
  • Stem Cell Biology

Background:

  • Hematopoietic stem cells (HSCs) maintain blood cell production but decline with age.
  • DNA methylation changes in aged HSCs contribute to dysfunction.
  • Growth Arrest and DNA Damage-inducible proteins (Gadd45a, Gadd45b, Gadd45g) are involved in HSC activation, with Gadd45b potentially inducing DNA demethylation.

Purpose of the Study:

  • To investigate the role of Gadd45b in DNA methylation and age-related HSC changes.
  • To determine if Gadd45b-mediated methylation alterations impact HSC function.

Main Methods:

  • Whole-genome bisulfite sequencing (WGBS) on HSCs from GADD45B knockout and aged wild-type mice.
  • Peripheral blood and bone marrow analysis.
  • Competitive transplantation and single-cell culture assays.

Main Results:

  • Young GADD45B knockout HSCs exhibit increased DNA methylation compared to aged wild-type HSCs, with distinct methylation patterns.
  • These methylation alterations in knockout HSCs did not lead to a significant loss of functional potential.
  • Transcriptional changes associated with aging were not reflected in the methylation alterations observed.

Conclusions:

  • Altered DNA methylation sites in GADD45B knockout HSCs do not compromise HSC potential.
  • Identified methylation sites associated with HSC function can be prioritized for targeting age-related HSC decline.
  • Generated a searchable HSC DNA methylation database for future research.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.5K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K